Abstract: An oral pharmaceutical composition which comprises a polyglycerol ester of an unsaturated fatty acid and a drug which is very slightly soluble in water.

Abstract: The subject invention concerns novel dye compositions and a process for dyeing keratinous fibers, for example, hair, to give a pleasing and stable colored product. The dye composition is a novel combination of three elements to give a dye that, unexpectedly, has highly desirable dyeing properties. This unique combination comprises (1) a suitable organic compound to assist dye dispersion, (2) dye precursors including dopamine, D-dopa, L-dopa, D,L-dopa, or analogs thereof, and (3) iodate or periodate. Desired color variations can be obtained by the use of appropriate color modifiers.

Abstract: Hair care compositions are disclosed containing a combination of carboxyfunctional polydimethylsiloxane and a cationic, organic polymer. The compositions can be used as hair fixatives and as such may be formulated into aerosol, pump spray, lotion, cream or mousse type hair care products. The compositions are especially effective in providing flexible, long-lasting hold to hair styles.

Abstract: A film-forming cosmetic composition useful as a facial pack, nail enamel, eye liner etc., which comprises a copolymer of vinyl alcohol and alkyl vinyl ether, being referred to simply as PVA/AVE, consisting of 98 to 80 mole % of vinyl alcohol monomer units and 2 to 20 mole % of linear or branched alkyl vinyl monomer units having from 1 to 6 carbon atoms. The molar ratio of the vinyl alcohol monomer units to the alkyl vinyl ether monomer units is in the range of from 95/5 to 85/15. The PVA/AVE according to the invention has no acetic groups with ester bonds in a molecule. Instead, there are alkyl or alkenyl groups having ether bonds which serve for steric hindrance for preventing gelation of an aqueous solution of such copolymer. From this reason, the PVA/AVE does not undergo any hydrolysis as time passes and is thus excellent in storage stability.

Abstract: Formulations of a cationic dye component (e.g., Azure A-Azure B-Azure C mixtures), an anionic dye component (e.g., Eosin Y) and an alcohol solvent (e.g., methanol or methanol-glycerol mixtures) are stabilized by an amino acid or its acid addition salt (e.g. lysine hydrochloride or glycine or a mixture of these).

Abstract: An air deodorizer, and a method for deodorizing rooms therewith, utilizing an aerosol of a solution containing from 2-25% by weight of non-toxic, non-oxidizing, deodorizing agent, said solution constituting liquid droplets having a weight average droplet size of less than 50 microns, more than 90% of said droplets having a size, by count, of less than 10 microns.

Abstract: Trialkylamine borane compounds are useful as antihyperlipidemic agents for lowering serum cholesterol and triglyceride levels in mammals.

Abstract: A method for the treatment and/or prophylaxis of incontinence in mammals, which method comprises administering to the mammal in need of said treatment an effective amount of a compound of formula (I): ##STR1## wherein R.sub.1 -R.sub.8 and X are as set forth herein.

Abstract: A method for preparing biological specimens for the scanning electron microscope utilizes a select group of fluorocarbon solvents. Replacement of drying solvents with a fluorocarbon solvent, followed by direct sublimation, provides comparable results to critical point drying.

Abstract: Tinnitus symptoms are treated with aminooxyacetic acid (AOAA) administered orally at dosages of 200-300 mg/day. Clinically significant reductions in tinnitus symptoms were observed.

Abstract: The present invention relates to a stabilized plant protecting agent suspension which can be characterized by containing 10 to 60% by weight of one or more active ingredients, 30 to 5% by weight of oily layer, 0 to 10% by weight of emulsifier, 10 to 20% by weight of conventionally used excipient and water needed to 100% by weight while by increasing solid concentration oil concentration decreases. The invention also provides a process for the preparation of a stabilized plant protecting agent suspension by adding oil and optionally an emulsifier and/or water containing layer to a suspension of a suitable particle size of the active ingredient and water soluble excipients, such as surfactants, optionally emulsifiers, dispersing agents, viscosity modifying agents, protective colloids and mixing together the suspension layer and the layer containing the oil with a stirrer of great shearing force and optionally adding to the obtained stabilized suspension further excipients, e.g.

Abstract: There is disclosed a substituted nitroimidazole compound, 1-methyl-2-methylsulfonyl-4-nitroimidazole which is an antiprotozoal and bactericidal compound with the unique and surprising property of being totally non-mutagenic and thus of a much higher degree of safety than is found with other nitroimidazoles. Compositions and methods for the antiprotozoal and bactericidal uses of such compounds are also disclosed.

Abstract: A hair treatment composition comprising 0.1% by weight or more of 3,4,4'-trichlorocarbanilide and 0.03% by weight or more of vitamine E acetate in an aqueous medium.This hair treatment composition can effectively prevent dandruff in the hair without causing adverse side effects to the skin or scalp.

Abstract: A method of prophylactics with respect to detoxification of Staphylococcus aureus and other toxins by ascorbic acid, salts and esters, topically applied by means of carriers which are otherwise regularly employed in the area where Staphylococcus aureus or other bacteria colonize, such as a pharmacological appliance including gauze pads, an absorbant mass or pad associated with menses, douches, and contraceptive compositions.

Abstract: Novel diolefin insect pheromone mimics are used to disrupt the sexual communication between insects when applied to an agricultural area in behaviorally effective amounts as follows: (Z)-1,12-heptadecadiene used for Heliothis zea Boddie; (Z)-15-methyl-1,9-heptadecadiene used for Trogoderma variable; (E)-15-methyl-1,9-heptadecadiene used for Trogoderma glabrum; and (Z,Z)-1,12,14-heptadecatriene used for Amyelois transitella.

Abstract: A method of prophylactics with respect to deodorization by ascorbic acid, salts and esters, topically applied by means of carriers which are otherwise regularly employed in the vaginal area, such as a pharmacological appliance including gauze pads, an absorbant mass or pad associated with menses, douches, and contraceptive compositions.

Abstract: A formulation for atraumatic nail removal containing 0.05-1.5 parts by weight of an azole derivative, 5-60 parts by weight of urea, 0-40 parts by weight of lipophilic wetting agent, 0-30 parts by weight of a factor conferring consistency, 0-40 parts by weight of an oil body or spreading agent, 0-0.2 parts by weight of a stabilizer and 20-60 parts by weight of vehicle.

Abstract: Insect infestation of grain is controlled by contacting the grain, or a locus separating the grain from an insect population, with an insecticidally effective amount of a liquid comprising a concentration of phosphatides greater than that found in crude vegetable oils. The dust associated with the grain is controlled as well when the grain is contacted with the liquid.

Abstract: Insecticidal and/or acaricidal composition and process for destroying insects, including termites. In an appropriate vehicle, the composition contains as its active substance one or more compounds corresponding to the following general formula: ##STR1## in which: R and R', which may be identical or different, represent a methyl or methylene radical,m and n, which may identical or different, stand for 0 or a whole number from 1 to 12, andp=0 when the heterocycle is pyrroline-1, or p=1 when the heterocycle is pyrrolidine; and the isomers and salts of said compounds of formula (I).

Abstract: A method for inhibiting unplanned or premature detrusor muscle contractions while at the same time increasing the force of contraction of the detrusor muscle is provided. The method comprises administering to the patient a di-N-substituted aminoethyl ester of diphenylthioacetic acid having the formula: ##STR1## in which R represents a disubstituted amino radical of the group consisting of the diethylamino group, the morpholino group or the piperidino group.